14.15
Brainsway Ltd Adr stock is traded at $14.15, with a volume of 49,628.
It is down -2.48% in the last 24 hours and down -10.44% over the past month.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
See More
Previous Close:
$14.51
Open:
$14.55
24h Volume:
49,628
Relative Volume:
0.43
Market Cap:
$568.67M
Revenue:
$56.60M
Net Income/Loss:
$8.82M
P/E Ratio:
63.28
EPS:
0.2236
Net Cash Flow:
$12.12M
1W Performance:
-1.05%
1M Performance:
-10.44%
6M Performance:
+13.65%
1Y Performance:
+77.21%
Brainsway Ltd Adr Stock (BWAY) Company Profile
Compare BWAY vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BWAY
Brainsway Ltd Adr
|
14.15 | 601.63M | 56.60M | 8.82M | 12.12M | 0.2236 |
|
ABT
Abbott Laboratories
|
108.33 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
94.17 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
303.13 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
47.80 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.90 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Brainsway Ltd Adr Stock (BWAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-16-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-03-22 | Initiated | Loop Capital | Buy |
| Jul-19-21 | Initiated | H.C. Wainwright | Buy |
| Apr-20-21 | Initiated | Northland Capital | Outperform |
| May-13-19 | Initiated | Cantor Fitzgerald | Overweight |
| May-13-19 | Initiated | Ladenburg Thalmann | Buy |
| May-13-19 | Initiated | Oppenheimer | Outperform |
| May-13-19 | Initiated | Raymond James | Outperform |
View All
Brainsway Ltd Adr Stock (BWAY) Latest News
BrainsWay Ltd.ADR Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
HC Wainwright Issues Negative Outlook for Brainsway Earnings - MarketBeat
What is HC Wainwright's Estimate for Brainsway Q3 Earnings? - MarketBeat
Wall Street Analysts See a 30.07% Upside in Brainsway (BWAY): Can the Stock Really Move This High? - Yahoo Finance
Brainsway (NASDAQ:BWAY) Shares Down 5.3%Here's Why - MarketBeat
Brainsway (BWAY) Upgraded to Buy: Here's Why - Yahoo! Finance Canada
Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Brainsway Q2 Earnings Call Highlights - Yahoo Finance
Brainsway (NASDAQ:BWAY) Reaches New 12-Month High After Strong Earnings - MarketBeat
Brainsway (NASDAQ:BWAY) Stock Price Up 13% on Analyst Upgrade - MarketBeat
Sei Investments Co. Acquires 163,925 Shares of Brainsway Ltd. Sponsored ADR $BWAY - marketbeat.com
Renaissance Technologies LLC Buys 241,560 Shares of Brainsway Ltd. Sponsored ADR $BWAY - MarketBeat
Brainsway Ltd. Sponsored ADR $BWAY Stock Position Raised by Masters Capital Management LLC - MarketBeat
Zacks Names Brainsway (NASDAQ: BWAY) Bull Of The Day While Lululemon (NASDAQ: LULU) Earns Bear Designation - foreignpolicyjournal.com
Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), Brainsway (BWAY) and Argenx Se (ARGX) - The Globe and Mail
Brainsway (NASDAQ:BWAY) Sets New 12-Month HighStill a Buy? - MarketBeat
Brainsway and Lululemon athletica have been highlighted as Zacks Bull and Bear of the Day - TradingView
Bull of the Day: Brainsway (BWAY) - sharewise.com
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Zacks Industry Outlook Highlights Terumo, QuidelOrtho, Lumexa Imaging and Brainsway - TradingView
Brainsway (NASDAQ:BWAY) Shares Up 5.5%Still a Buy? - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Best Momentum Stocks to Buy for July 14th - The Globe and Mail
Brainsway (NASDAQ:BWAY) Shares Down 6.8%Here's Why - MarketBeat
Y.D. More Investments Ltd Raises Stake in Brainsway Ltd. Sponsored ADR $BWAY - MarketBeat
BWAYBrainsway Ltd ADR Options - Finviz
BrainsWay Ltd. (BWAY) stock price, news, quote and history - Yahoo Finance Singapore
Strength Seen in Brainsway (BWAY): Can Its 5.3% Jump Turn into More Strength? - MSN
Are medical stocks lagging Brainsway (BWAY) this year? - MSN
BrainsWay (BWAY) Holds Steady with Modest Gain as Support and Resistance Levels Come into FocusOvervalued Signals - newsline.com
BrainsWay Announces Minority-Stake Investment in Hopemark Health - ChartMill
BWAY Stock Price, Quote & Chart | BRAINSWAY LTD-ADR (NASDAQ:BWAY) - ChartMill
Brainsway Q1 Earnings Call Highlights - Yahoo Finance
BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights - ChartMill
Brainsway (NASDAQ:BWAY) Reaches New 52-Week HighTime to Buy? - MarketBeat
Are Medical Stocks Lagging Brainsway (BWAY) This Year? - Yahoo Finance
Recent price trend in Brainsway (BWAY) is your friend, here's why - MSN
Brainsway (NASDAQ:BWAY) Sets New 1-Year HighWhat's Next? - MarketBeat
Brainsway Ltd Adr Stock (BWAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):